Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Management of Locally Advanced Pancreatic Cancer: Results of an International Survey of Current Practice.

Reames BN, Blair AB, Krell RW, Groot VP, Gemenetzis G, Padussis JC, Thayer SP, Falconi M, Wolfgang CL, Weiss MJ, Are C, He J.

Ann Surg. 2019 Aug 21. doi: 10.1097/SLA.0000000000003568. [Epub ahead of print]

PMID:
31449138
2.

Postoperative surveillance of pancreatic cancer patients.

Daamen LA, Groot VP, Intven MPW, Besselink MG, Busch OR, Koerkamp BG, Mohammad NH, Hermans JJ, van Laarhoven HWM, Nuyttens JJ, Wilmink JW, van Santvoort HC, Molenaar IQ, Stommel MWJ; Dutch Pancreatic Cancer Group.

Eur J Surg Oncol. 2019 Oct;45(10):1770-1777. doi: 10.1016/j.ejso.2019.05.031. Epub 2019 Jun 1. Review.

PMID:
31204168
3.

Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer.

Groot VP, Mosier S, Javed AA, Teinor JA, Gemenetzis G, Ding D, Haley LM, Yu J, Burkhart RA, Hasanain A, Debeljak M, Kamiyama H, Narang A, Laheru DA, Zheng L, Lin MT, Gocke CD, Fishman EK, Hruban RH, Goggins MG, Molenaar IQ, Cameron JL, Weiss MJ, Velculescu VE, He J, Wolfgang CL, Eshleman JR.

Clin Cancer Res. 2019 Aug 15;25(16):4973-4984. doi: 10.1158/1078-0432.CCR-19-0197. Epub 2019 May 29.

PMID:
31142500
4.

Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.

Groot VP, Gemenetzis G, Blair AB, Rivero-Soto RJ, Yu J, Javed AA, Burkhart RA, Rinkes IHMB, Molenaar IQ, Cameron JL, Weiss MJ, Wolfgang CL, He J.

Ann Surg. 2019 Jun;269(6):1154-1162. doi: 10.1097/SLA.0000000000002734.

PMID:
31082915
5.

Lessons learned by features of pancreatic ductal adenocarcinoma and its tumor microenvironment.

Blair AB, Groot VP, He J.

Ann Transl Med. 2019 Mar;7(Suppl 1):S9. doi: 10.21037/atm.2019.01.32. No abstract available.

6.

Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer.

Groot VP, Blair AB, Gemenetzis G, Ding D, Burkhart RA, Yu J, Borel Rinkes IHM, Molenaar IQ, Cameron JL, Weiss MJ, Wolfgang CL, He J.

Eur J Surg Oncol. 2019 Sep;45(9):1674-1683. doi: 10.1016/j.ejso.2019.04.007. Epub 2019 Apr 11.

PMID:
31023560
7.

Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival.

Groot VP, Blair AB, Gemenetzis G, Ding D, Burkhart RA, van Oosten AF, Molenaar IQ, Cameron JL, Weiss MJ, Yang SC, Wolfgang CL, He J.

HPB (Oxford). 2019 Aug;21(8):998-1008. doi: 10.1016/j.hpb.2018.12.002. Epub 2019 Feb 15.

PMID:
30777697
8.

Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinoma.

Gemenetzis G, Groot VP, Blair AB, Ding D, Thakker SS, Fishman EK, Cameron JL, Makary MA, Weiss MJ, Wolfgang CL, He J.

J Surg Oncol. 2018 Dec;118(8):1277-1284. doi: 10.1002/jso.25288. Epub 2018 Oct 31.

PMID:
30380143
9.

ASO Author Reflections: Do Distinct Patterns of Recurrence Impact the Prognosis of Patients With Resected Pancreatic Ductal Adenocarcinoma?

Groot VP, Wolfgang CL, He J.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):806-807. doi: 10.1245/s10434-018-6820-z. Epub 2018 Oct 8. No abstract available.

PMID:
30298312
10.

The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis.

Daamen LA, Groot VP, Goense L, Wessels FJ, Borel Rinkes IH, Intven MPW, van Santvoort HC, Molenaar IQ.

Eur J Radiol. 2018 Sep;106:128-136. doi: 10.1016/j.ejrad.2018.07.010. Epub 2018 Jul 12. Review.

PMID:
30150034
11.

Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status: Results of the Prospective CLUSTER Study.

Gemenetzis G, Groot VP, Yu J, Ding D, Teinor JA, Javed AA, Wood LD, Burkhart RA, Cameron JL, Makary MA, Weiss MJ, He J, Wolfgang CL.

Ann Surg. 2018 Sep;268(3):408-420. doi: 10.1097/SLA.0000000000002925.

PMID:
30080739
12.

Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.

Groot VP, Gemenetzis G, Blair AB, Ding D, Javed AA, Burkhart RA, Yu J, Borel Rinkes IH, Molenaar IQ, Cameron JL, Fishman EK, Hruban RH, Weiss MJ, Wolfgang CL, He J.

Ann Surg Oncol. 2018 Aug;25(8):2475-2483. doi: 10.1245/s10434-018-6558-7. Epub 2018 Jun 14.

13.

Immunolabeling of Cleared Human Pancreata Provides Insights into Three-Dimensional Pancreatic Anatomy and Pathology.

Noë M, Rezaee N, Asrani K, Skaro M, Groot VP, Wu PH, Olson MT, Hong SM, Kim SJ, Weiss MJ, Wolfgang CL, Makary MA, He J, Cameron JL, Wirtz D, Roberts NJ, Offerhaus GJA, Brosens LAA, Wood LD, Hruban RH.

Am J Pathol. 2018 Jul;188(7):1530-1535. doi: 10.1016/j.ajpath.2018.04.002. Epub 2018 Apr 22.

14.

Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients.

Ryan JF, Rosati LM, Groot VP, Le DT, Zheng L, Laheru DA, Shin EJ, Jackson J, Moore J, Narang AK, Herman JM.

Oncotarget. 2018 Mar 27;9(23):16427-16436. doi: 10.18632/oncotarget.24713. eCollection 2018 Mar 27.

15.

Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection.

Gemenetzis G, Groot VP, Blair AB, Laheru DA, Zheng L, Narang AK, Fishman EK, Hruban RH, Yu J, Burkhart RA, Cameron JL, Weiss MJ, Wolfgang CL, He J.

Ann Surg. 2019 Aug;270(2):340-347. doi: 10.1097/SLA.0000000000002753.

PMID:
29596120
16.

Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.

Groot VP, Gemenetzis G, Blair AB, Rivero-Soto RJ, Yu J, Javed AA, Burkhart RA, Rinkes IHMB, Molenaar IQ, Cameron JL, Weiss MJ, Wolfgang CL, He J.

Ann Surg. 2018 Mar 23. doi: 10.1097/SLA.0000000000002734. [Epub ahead of print]

17.

Lessons learned from 29 lymphoepithelial cysts of the pancreas: institutional experience and review of the literature.

Groot VP, Thakker SS, Gemenetzis G, Noë M, Javed AA, Burkhart RA, Noveiry BB, Cameron JL, Weiss MJ, VandenBussche CJ, Fishman EK, Hruban RH, Wolfgang CL, Lennon AM, He J.

HPB (Oxford). 2018 Jul;20(7):612-620. doi: 10.1016/j.hpb.2018.01.003. Epub 2018 Mar 9. Review.

18.

IPMNs with co-occurring invasive cancers: neighbours but not always relatives.

Felsenstein M, Noë M, Masica DL, Hosoda W, Chianchiano P, Fischer CG, Lionheart G, Brosens LAA, Pea A, Yu J, Gemenetzis G, Groot VP, Makary MA, He J, Weiss MJ, Cameron JL, Wolfgang CL, Hruban RH, Roberts NJ, Karchin R, Goggins MG, Wood LD.

Gut. 2018 Sep;67(9):1652-1662. doi: 10.1136/gutjnl-2017-315062. Epub 2018 Mar 2.

PMID:
29500184
19.

Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer.

Daamen LA, Groot VP, Heerkens HD, Intven MPW, van Santvoort HC, Molenaar IQ.

HPB (Oxford). 2018 Apr;20(4):297-304. doi: 10.1016/j.hpb.2017.11.009. Epub 2018 Feb 1.

20.

Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?

He J, Blair AB, Groot VP, Javed AA, Burkhart RA, Gemenetzis G, Hruban RH, Waters KM, Poling J, Zheng L, Laheru D, Herman JM, Makary MA, Weiss MJ, Cameron JL, Wolfgang CL.

Ann Surg. 2018 Jul;268(1):1-8. doi: 10.1097/SLA.0000000000002672.

21.

BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal Adenocarcinoma.

Blair AB, Groot VP, Gemenetzis G, Wei J, Cameron JL, Weiss MJ, Goggins M, Wolfgang CL, Yu J, He J.

J Am Coll Surg. 2018 Apr;226(4):630-637.e1. doi: 10.1016/j.jamcollsurg.2017.12.021. Epub 2018 Jan 5.

22.

Analogous detection of circulating tumor cells using the AccuCyte® -CyteFinder® system and ISET system in patients with locally advanced and metastatic prostate cancer.

van der Toom EE, Groot VP, Glavaris SA, Gemenetzis G, Chalfin HJ, Wood LD, Wolfgang CL, de la Rosette JJMCH, de Reijke TM, Pienta KJ.

Prostate. 2018 Mar;78(4):300-307. doi: 10.1002/pros.23474. Epub 2017 Dec 29.

PMID:
29285777
23.

Use of imaging during symptomatic follow-up after resection of pancreatic ductal adenocarcinoma.

Groot VP, Daamen LA, Hagendoorn J, Borel Rinkes IHM, van Santvoort HC, Molenaar IQ.

J Surg Res. 2018 Jan;221:152-160. doi: 10.1016/j.jss.2017.08.023. Epub 2017 Sep 21.

PMID:
29229122
24.

Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective.

Ryan JF, Groot VP, Rosati LM, Hacker-Prietz A, Narang AK, McNutt TR, Jackson JF, Le DT, Jaffee EM, Zheng L, Laheru DA, He J, Pawlik TM, Weiss MJ, Wolfgang CL, Herman JM.

Ann Surg Oncol. 2018 Jan;25(1):280-289. doi: 10.1245/s10434-017-6134-6. Epub 2017 Oct 23.

PMID:
29063299
25.

Current Strategies for Detection and Treatment of Recurrence of Pancreatic Ductal Adenocarcinoma After Resection: A Nationwide Survey.

Groot VP, Daamen LA, Hagendoorn J, Borel Rinkes IHM, Busch OR, van Santvoort HC, Besselink MG, Molenaar IQ; Dutch Pancreatic Cancer Group.

Pancreas. 2017 Oct;46(9):e73-e75. doi: 10.1097/MPA.0000000000000899. No abstract available.

PMID:
28902799
26.

Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.

Groot VP, Rezaee N, Wu W, Cameron JL, Fishman EK, Hruban RH, Weiss MJ, Zheng L, Wolfgang CL, He J.

Ann Surg. 2018 May;267(5):936-945. doi: 10.1097/SLA.0000000000002234.

PMID:
28338509
27.

Systematic review on the treatment of isolated local recurrence of pancreatic cancer after surgery; re-resection, chemoradiotherapy and SBRT.

Groot VP, van Santvoort HC, Rombouts SJ, Hagendoorn J, Borel Rinkes IH, van Vulpen M, Herman JM, Wolfgang CL, Besselink MG, Molenaar IQ.

HPB (Oxford). 2017 Feb;19(2):83-92. doi: 10.1016/j.hpb.2016.11.001. Epub 2017 Jan 3. Review.

28.

Rare Case of an Epithelial Cyst in an Intrapancreatic Accessory Spleen Treated by Robot-Assisted Spleen Preserving Distal Pancreatectomy.

van Dijck WP, Groot VP, Brosens LA, Hagendoorn J, Rinkes IH, van Leeuwen MS, Molenaar IQ.

Case Rep Gastrointest Med. 2016;2016:9475897. Epub 2016 Oct 25.

Supplemental Content

Loading ...
Support Center